Moolec Science Stock Forward View - Triple Exponential Smoothing
| MLEC Stock | 9.95 -0.28 -2.74% |
Momentum
Impartial
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth 9.483 |
This view frames how Moolec Science SA responds to recent headlines and peer activity within its market context.
The Triple Exponential Smoothing forecasted value of Moolec Science SA on the next trading day is expected to be 9.95 with a mean absolute deviation of 0.82 and the sum of the absolute errors of 48.32.Moolec Science after-hype prediction price | $ 9.95 |
Hype metrics are shown as one component among forecasting, technical, analyst, and earnings context.
Cross-verify projections for Moolec Science using Historical Fundamental Analysis of Moolec Science. The historical view provides additional context.Moolec Science Additional Predictive Modules
Predictive models for Moolec Science combine technical indicators with statistical methods to estimate probable price trajectories. Ensemble techniques that blend multiple model outputs often produce more stable predictions than any single model.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Triple Exponential Smoothing Price Forecast For the 17th of March 2026
Given 90 days horizon, the Triple Exponential Smoothing forecasted value of Moolec Science SA on the next trading day is expected to be 9.95 with a mean absolute deviation of 0.82 , mean absolute percentage error of 1.76 , and the sum of the absolute errors of 48.32 .Please note that although there have been many attempts to predict Moolec Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Moolec Science's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Moolec Science | Moolec Science Price Prediction | Research Analysis |
Forecasted Value
The next-day forecast for Moolec Science SA focuses on identifying predictive downside and upside bands that can frame a realistic trading range. Used properly, these levels provide context around forecast dispersion rather than certainty about the next closing print.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Moolec Science stock data series using in forecasting. Note that when a statistical model is used to represent Moolec Science stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0858 |
| MAD | Mean absolute deviation | 0.819 |
| MAPE | Mean absolute percentage error | 0.1093 |
| SAE | Sum of the absolute errors | 48.32 |
Mean reversion in Moolec Science's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
After-Hype Price Density Analysis
Understanding Moolec Science's probability distribution helps investors calibrate position size to their risk tolerance. The tails of the Moolec Science distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Using Moolec Science's historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. Moolec Science's after-hype downside and upside margins for the prediction period are 0.50 and 32.16, respectively. Note that past news reactions for Moolec Science are not guaranteed to repeat, particularly in novel market environments.
Current Value
The after-hype framework applied to Moolec Science SA assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Moolec Science is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Moolec Science backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Moolec Science, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
3.00 | 22.21 | 4.71 | 0.98 | 9 Events | 6 Events | In 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
9.95 | 9.95 | 0.00 |
|
Hype Timeline
Moolec Science SA is now traded for 9.95. The company has historical hype elasticity of 4.71, and average elasticity to hype of competition of -0.98. Moolec is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 3.0%. %. The volatility of related hype on Moolec Science is about 6812.88%, with the expected price after the next announcement by competition of 8.97. About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Moolec Science SA recorded a loss per share of 258.69. The company had not issued any dividends in recent years. The firm completed a 1:15 stock split on 5th of January 2026. Given the investment horizon of 90 days the next forecasted press release will be in 9 days. Cross-verify projections for Moolec Science using Historical Fundamental Analysis of Moolec Science. The historical view provides additional context.Related Hype Analysis
Understanding how Moolec Science's direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect Moolec Science's performance.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VRAX | Virax Biolabs Group | -0.03 | 4 per month | 0.00 | -0.21 | 8.57 | -9.76 | 23.38 | |
| ELAB | Elevai Labs Common | 0.18 | 7 per month | 0.00 | -0.39 | 8.62 | -23.72 | 53.38 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 12.78 | 0.13 | 35.14 | -14.29 | 298.33 | |
| GLMD | Galmed Pharmaceuticals | -0.01 | 4 per month | 0.00 | -0.17 | 7.59 | -7.62 | 21.94 | |
| WINT | Windtree Therapeutics | -1.74 | 4 per month | 0.00 | -0.09 | 0.00 | -25.00 | 150.00 | |
| GTBP | GT Biopharma | 0.02 | 8 per month | 0.00 | -0.07 | 8.33 | -10.64 | 37.01 | |
| TIVC | Tivic Health Systems | -0.09 | 8 per month | 0.00 | -0.18 | 6.38 | -8.07 | 33.19 | |
| DRMA | Dermata Therapeutics | -1.74 | 8 per month | 0.00 | -0.06 | 16.48 | -16.23 | 80.83 | |
| XRTX | XORTX Therapeutics | 0.01 | 5 per month | 0.00 | -0.12 | 7.02 | -8.33 | 25.64 | |
| NCEL | NewcelX | 0.14 | 4 per month | 0.00 | -0.04 | 11.55 | -12.61 | 39.40 |
Other Forecasting Options for Moolec Science
The price movement of Moolec is a central concern for all potential investors, regardless of their level of expertise. Moolec Stock price charts can be difficult to interpret due to the noise present in the data.Moolec Science Related Equities
The following equities are related to Moolec Science within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Moolec Science against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Moolec Science Market Strength Events
Market strength indicators applied to Moolec Science stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell Moolec Science SA.
Moolec Science Risk Indicators
Risk indicator analysis for Moolec Science is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in Moolec Science's investment, investors can make informed decisions about position sizing and risk mitigation.
| Mean Deviation | 12.09 | |||
| Semi Deviation | 11.03 | |||
| Standard Deviation | 21.56 | |||
| Variance | 464.83 | |||
| Downside Variance | 145.1 | |||
| Semi Variance | 121.59 | |||
| Expected Short fall | -16.94 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Moolec Science
A coverage review of Moolec Science SA helps investors see when the security is attracting above-average attention from contributors and market observers. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Moolec Science Short Properties
A short-interest review of Moolec Science SA helps investors understand whether skepticism in the market is becoming more influential. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 430.9 K | |
| Cash And Short Term Investments | 9 M |
More Resources for Moolec Stock Analysis
A comprehensive view of Moolec Science SA starts with financial statements and ratio context. Ratios and trend metrics help frame Moolec Science's operating context across reporting periods. Key reports that frame Moolec Science SA Stock are listed below:Cross-verify projections for Moolec Science using Historical Fundamental Analysis of Moolec Science. The historical view provides additional context. Moolec Science currently shows ROE of -1.75%, market cap of 7.43 Million. This analysis of Moolec Science works best as a complementary layer when evaluating how the security fits in a broader portfolio. Moolec Science analysis across multiple dimensions - risk, valuation, diversification - produces a more informed position-sizing decision. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Earnings Share -258.69 | Revenue Per Share | Quarterly Revenue Growth 9.483 | Return On Assets | Return On Equity |
Investors evaluate Moolec Science SA using market value and book value, each describing different facets of the business. Moolec Science's market capitalization is 7.43 M. Moolec Science P/B of 1.07 shows the market assigns a modest premium over accounting equity. Enterprise value stands at 245.29 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
It is useful to distinguish Moolec Science's value from its trading price, which are computed with different methods. For Moolec Science, key inputs include a P/B ratio of 1.07, ROE of -1.75%, and revenue of 333.61 M. Where Moolec Science trades at any moment depends on the balance of buying and selling pressure.